Loncar Cancer Immunotherapy ETF (CNCR) ETF

Expense Ratio: 0.79% | AUM: 37.56M | Issuer: Exchange Traded Concepts

CNCR Daily Price Range
CNCR 52-Week Price Range

CNCR - Real-Time SMART Grade™

B
Buy

Overall SMART Grade

CNCR has a real-time SMART Grade of B (Buy).

Learn More About SMART Grades™

CNCR - Profile & Info


The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.

Issuer Exchange Traded Concepts
Expense Ratio 0.79%
Assets Under Management (AUM) 37.56M
Underlying Index Loncar Cancer Immunotherapy Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $21.46
Options? Yes
Total Holdings 27

CNCR - Top Holdings

Symbol Holding Name % of Total

CNCR - Top Stories


View All CNCR News

CNCR - Price/Volume Stats

Current price $21.65
Prev. close $21.52
Day low $20.70
Day high $21.65
52-week high $24.57
52-week low $17.82
Day Volume 18,100
Avg. volume 14,267
Dividend yield 0.00%

CNCR - Recent Returns

1-mo -0.90%
3-mo -7.72%
6-mo 11.14%
1-year -0.37%
3-year -6.79%
5-year N/A
YTD -7.64%
2019 24.22%
2018 -20.65%
2017 13.61%
2016 -25.63%
2015 N/A

CNCR - Stock Chart


CNCR - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular Articles



Page generated in 3.0183 seconds.